Mask mandates are back in several Bay Area counties as health officials prepare for a winter surge in respiratory illnesses. Starting Nov. 1, healthcare workers and some patients will be required to wear masks in patient care areas to protect vulnerable populations.
Sam Terblanche, a Columbia University junior, tragically died after being misdiagnosed in the emergency room. Despite seeking help for severe symptoms, he was sent home twice. His father's fight for justice reveals the troubling state of emergency care.
In a shocking turn of events, 22-year-old Leticia Paul died after a routine CT scan triggered a fatal allergic reaction, prompting an investigation into the hospital's protocols and patient safety measures.
As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Robert F. Kennedy Jr. proposes expanding access to experimental medical treatments, acknowledging potential risks from unlicensed providers. Is this a step forward or a danger to public health?
A cautionary tale from a geriatrician reveals the risks of cannabis gummies for seniors. A 76-year-old's experience highlights the importance of proper dosage and awareness of drug interactions.
Infections from the drug-resistant fungus Candida auris are rising alarmingly in U.S. hospitals, posing a significant risk to already sick patients. Despite being manageable for healthy individuals, its resistance to treatments makes it a growing concern in healthcare settings.
